Clinical Trials Logo

Locally Advanced Gastric Cancer clinical trials

View clinical trials related to Locally Advanced Gastric Cancer.

Filter by:

NCT ID: NCT03192735 Active, not recruiting - Neoadjuvant Therapy Clinical Trials

Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric Cancer

Start date: September 1, 2017
Phase: Phase 2
Study type: Interventional

We star a multicentre, one-armed, clinical pilot trial intends to investigate the safety and effectiveness of Apatinib Combined With Oxaliplatin, Gimeracil and Oteracil Porassium Capsules Neoadjuvant Ttherapy for Locally Advanced Gastric Cancer(cT2-4/N+M0)

NCT ID: NCT02855788 Recruiting - Clinical trials for Metastatic Gastric Cancer

Metronomic Chemotherapy in Advanced Gastric Cancer

Start date: May 2015
Phase: Phase 2
Study type: Interventional

phase II study of weekly metronomic chemotherapy using weekly Paclitaxel, Oxaliplatin, Leucovorin and 5-FU (POLF) in patients with advanced gastric cancer

NCT ID: NCT02365896 Not yet recruiting - Clinical trials for Locally Advanced Gastric Cancer

Comparison of Short Term Outcomes Between Totally Laparoscopic and Laparoscopy-Assisted Distal Gastrectomy With Billroth-II Reconstruction and D2 Lymphadenectomy for Locally Advanced Gastric Cancer

Start date: June 2015
Phase: N/A
Study type: Interventional

Prospective Randomized Controlled Multicenter Clinical Trial for Comparison of Safety Between Totally Laparoscopic Distal Gastrectomy(TLDG) and Laparoscopy-Assisted Distal Gastrectomy(LADG) With Billroth-II Reconstruction and D2 Lymphadenectomy for Locally Advanced Gastric Cancer

NCT ID: NCT02302794 Recruiting - Clinical trials for Locally Advanced Gastric Cancer

A Multicenter Clinical Trial on Laparoscopic Gastric Cancer Surgery Compared With Open Surgery

Start date: August 2014
Phase: Phase 3
Study type: Interventional

evaluate the long-term efficacy and safety of oncology between D2 laparoscopic approach distal gastric resection (distal gastrectomy, D2 lymph node dissection) with the current standard surgical treatment model D2 open approach distal gastric resection (distal gastrectomy, D2 lymphadenectomy).

NCT ID: NCT02192983 Completed - Clinical trials for Locally Advanced Gastric Cancer

A Comparison of XELOX Regimen and EOX Regimen as Neoadjuvant Chemotherapy Regimen for Locally Advanced Gastric Cancer.

Start date: November 2008
Phase: N/A
Study type: Observational [Patient Registry]

This study is designed to assess what is the better neoadjuvant chemotherapy regimen for patients with initially unresectable locally advanced gastric cancer.